NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-221-1993-3-BE-30 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BE EP 04030912.2 Abandoned
NCI E-221-1993-3-BG-31 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BG EP 04030912.2 Abandoned
NCI E-221-1993-3-AL-27 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AL EP 04030912.2 Abandoned
NCI E-221-1993-3-AT-28 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AT EP 04030912.2 Abandoned
NCI E-221-1993-3-HU-44 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders HU EP 04030912.2 Abandoned
NCI E-221-1993-3-IS-46 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IS EP 04030912.2 Abandoned
NCI E-221-1993-3-GR-42 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GR EP 04030912.2 Abandoned
NCI E-221-1993-3-IT-47 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IT EP 04030912.2 Abandoned
NCI E-221-1993-3-IE-45 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disordersz IE EP 04030912.2 Abandoned
NCI E-221-1993-3-EP-23 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EP DIV 04030912.2 Abandoned
NCI E-221-1993-3-DK-36 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DK EP 04030912.2 Abandoned
NCI E-221-1993-3-CZ-34 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CZ EP 04030912.2 Abandoned
NCI E-221-1993-3-EE-37 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EE EP 04030912.2 Abandoned
NCI E-221-1993-3-CY-33 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CY EP 04030912.2 Abandoned
NCI E-221-1993-3-HR-43 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders HR EP 04030912.2 Abandoned
NCI E-221-1993-3-FI-39 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FI EP 04030912.2 Abandoned
NCI E-221-1993-3-TR-63 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders TR EP 04030912.2 Abandoned
NCI E-221-1993-3-CH-32 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CH EP 04030912.2 Abandoned
NCI E-221-1993-3-GB-41 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GB EP 04030912.2 Abandoned
NCI E-221-1993-3-CA-09 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CA National Stage 2173976 Abandoned
NCI E-221-1993-3-DE-16 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DE EP 94930694.8 Abandoned
NCI E-221-1993-3-FR-17 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FR EP 94930694.8 Abandoned
NCI E-221-1993-3-PT-20 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PT EP 94930694.8 Abandoned
NCI E-221-1993-3-ES-21 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders ES EP 94930694.8 Abandoned
NCI E-221-1993-3-CH-15 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CH EP 94930694.8 Abandoned
NCI E-221-1993-3-IT-19 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IT EP 94930694.8 Abandoned
NCI E-221-1993-3-IE-18 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IE EP 94930694.8 Abandoned
NCI E-221-1993-3-AT-13 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AT EP 94930694.8 Abandoned
NCI E-221-1993-3-BE-14 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BE EP 94930694.8 Abandoned
NCI E-221-1993-3-EP-02 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EP National Stage 94930694.8 Abandoned
NCI E-221-1993-3-GB-22 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GB EP 94930694.8 Abandoned
NCI E-221-1993-3-JP-10 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER JP National Stage 7-511977 Abandoned
NCI E-221-1993-3-PH-11 COMPOSITION AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER PH National Stage 94930694.8 Abandoned
NCI E-221-1993-3-IL-04 Compositions & Methods for Treating Pathologies Including Cancer IL National Stage 94930694.8 Abandoned
NCI E-221-1993-3-AU-08 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AU National Stage 79737/94 Abandoned
NCI E-214-1994-0-US-01 ENZYMATIC DEGRADING SUBTRACTION HYBRIDIZATION US ORD 08/322,075 5525471 Expired PDF
NCI E-221-1993-3-ZA-07 Composition and Methods for Treating Pathologies Including Cancer ZA National Stage 94/7964 Abandoned
NCI E-221-1993-3-PCT-01 PHENYLACETATE AND DERIVATIVES ALONE OR IN COMBINATION WITH OTHER COMPOUNDS AGAINST NEOPLASTIC CONDITIONS AND OTHER DISORDERS PCT PCT COMB PCT/US94/11492 Expired
NCI E-221-1993-3-KR-05 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders KR National Stage 96701885 Abandoned
NCI E-221-1993-3-JP-12 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP DIV 2002-302292 Abandoned
NCI E-221-1993-3-JP-03 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP National Stage 2001-69516 Abandoned
NIEHS E-016-1993-0-US-01 FLUORESCENT AND NMR SENSITIVE INTRACELLULAR PH INDICATORS US ORD 08/320,986 5639906 Expired PDF
NCI E-222-1993-0-AU-04 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS AU National Stage 79673/94 Abandoned
NCI E-222-1993-1-US-01 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS US CIP 08/319,888 5650442 Abandoned PDF
NCI E-222-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US94/11306 Expired
NCI E-222-1993-0-EP-05 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS EP National Stage 94930608.8 Abandoned
NCI E-124-1992-2-US-01 ENCAPSULATED AND NON-ENCAPSULATED NITRIC OXIDE GENERATORS USED AS ANTIMICROBIAL AGENTS US CIP 08/319,744 Abandoned
NCI E-245-1994-0-US-01 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CIP 08/319,467 5618536 Expired PDF
NIDDK E-069-1988-0-US-02 CARBAMATES RELATED TO (-)-PHYSOSTIGMINE AS CHOLINERGIC AGENTS US CON 08/319,245 Abandoned
NIEHS E-237-1994-4-US-01 ISOLATION OF BRCA1 GENE AND ITS INVOLVEMENT IN SPORADIC BREAST AND OVARIAN CANCER US ORD 08/319,511 Abandoned